T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor
- PMID: 2965738
- PMCID: PMC2188915
- DOI: 10.1084/jem.167.4.1417
T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor
Abstract
Interleukin-HP1 (HP1)/IL-6 is a 25-30-kD protein produced by macrophages, fibroblasts, and certain T cell lines. It was originally identified as a mouse growth factor for B cell hybridomas and plasmacytomas, and was recently shown to stimulate growth and differentiation of normal B cells. Here we demonstrate that, in the presence of lectins or anti-T cell receptor antibodies, HP1/IL-6 has a growth factor activity equivalent to that of IL-2 for mature thymic and peripheral T cells of both the L3T4+ and Lyt-2+ subsets. Contrary to IL-2 and IL-4, HP1/IL-6 was, however, not capable of supporting the growth of established T cell lines. In addition to its effects on T cell proliferation, HP1/IL-6 also enhanced the differentiation of mouse cytolytic T cell precursors in primary allogeneic mixed lymphocyte cultures. Fractionation of responding cell populations indicated that HP1/IL-6 was capable of restoring the response of accessory cell-depleted T cells to Con A. This observation suggests that the production of HP1/IL-6 by macrophages could, at least partly, explain their role in polyclonal T cell activation.
Similar articles
-
Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.J Exp Med. 1987 Mar 1;165(3):641-9. doi: 10.1084/jem.165.3.641. J Exp Med. 1987. PMID: 3493321 Free PMC article.
-
B cell growth and differentiation activity of interleukin-HP1 and related murine plasmacytoma growth factors. Synergy with interleukin 1.Eur J Immunol. 1988 Apr;18(4):607-12. doi: 10.1002/eji.1830180418. Eur J Immunol. 1988. PMID: 2452746
-
Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.J Immunol. 1990 Apr 15;144(8):3039-45. J Immunol. 1990. PMID: 1969882
-
Interleukin-6: possible implications in human diseases.Ric Clin Lab. 1989 Jan-Mar;19(1):1-10. doi: 10.1007/BF02871787. Ric Clin Lab. 1989. PMID: 2669108 Review.
-
Host defense against infections and inflammations: role of the multifunctional IL-6/IFN-beta 2 cytokine.Experientia. 1989 Jun 15;45(6):549-57. doi: 10.1007/BF01990505. Experientia. 1989. PMID: 2661256 Review.
Cited by
-
Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6.Clin Exp Immunol. 1989 Sep;77(3):324-30. Clin Exp Immunol. 1989. PMID: 2680182 Free PMC article.
-
Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy.J Exp Med. 1991 Dec 1;174(6):1511-5. doi: 10.1084/jem.174.6.1511. J Exp Med. 1991. PMID: 1744582 Free PMC article.
-
Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA.J Exp Med. 1990 Feb 1;171(2):389-400. doi: 10.1084/jem.171.2.389. J Exp Med. 1990. PMID: 2303779 Free PMC article.
-
Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture.Am J Pathol. 1993 Oct;143(4):1121-30. Am J Pathol. 1993. PMID: 8214006 Free PMC article.
-
Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.Thorax. 1996 Feb;51(2):150-4. doi: 10.1136/thx.51.2.150. Thorax. 1996. PMID: 8711646 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources